Recurrent High Grade B-Cell Lymphoma

Also known as: High Grade B-Cell Lymphoma-Recurrent

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB13915	Axicabtagene ciloleucel	1	Not Yet Recruiting	1
DB00531	Cyclophosphamide	1	Not Yet Recruiting	1
DB00531	Cyclophosphamide	1	Recruiting	2
DB01073	Fludarabine	1	Not Yet Recruiting	1
DB01073	Fludarabine	1	Recruiting	2
DB18115	Golcadomide	1	Recruiting	1
DB00073	Rituximab	1	Recruiting	1
DB12498	Mogamulizumab	1 / 2	Completed	1
DB09037	Pembrolizumab	1 / 2	Completed	1
DB00026	Anakinra	2	Completed	1
DB00026	Anakinra	2	Recruiting	1
DB13915	Axicabtagene ciloleucel	2	Completed	1
DB13915	Axicabtagene ciloleucel	2	Recruiting	1
DB01008	Busulfan	2	Withdrawn	1
DB00631	Clofarabine	2	Withdrawn	1
DB00531	Cyclophosphamide	2	Completed	1
DB00531	Cyclophosphamide	2	Recruiting	1
DB00531	Cyclophosphamide	2	Withdrawn	1
DB01073	Fludarabine	2	Completed	1
DB01073	Fludarabine	2	Recruiting	1
DB00441	Gemcitabine	2	Withdrawn	1
DB16222	Loncastuximab tesirine	2	Recruiting	1
DB18441	Maplirpacept	2	Recruiting	1
DB15434	Mosunetuzumab	2	Recruiting	1
DB00075	Muromonab	2	Recruiting	1
DB00688	Mycophenolate mofetil	2	Withdrawn	1
DB17116	Ontorpacept	2	Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	1
DB00073	Rituximab	2	Withdrawn	1
DB00864	Tacrolimus	2	Withdrawn	1
DB02546	Vorinostat	2	Withdrawn	1
DB15134	Fluoroazomycin arabinoside F-18	Not Available	Completed	1